Table 1 Demographic and clinical characteristics of the patients (n = 433)
From: Rising statin use and effect on ischemic stroke outcome
Treatment with statins | ||||
|---|---|---|---|---|
Variables | Yes (n = 95) | No (n = 338) | p | |
(mean ± SD) | ||||
Age, years | 75.4 ± 9.1 | 74.6 ± 15.3 | 0.62 | |
WBC, Thou/uL | 8.6 ± 3.8 | 8.6 ± 4.5 | 0.97 | |
Platelet, Thou/uL | 250.9 ± 76.7 | 254.8 ± 86.5 | 0.70 | |
Cholesterol, mg/dL | 181.2 ± 83.7 | 196.5 ± 46.1 | 0.03 | |
HDL, mg/dL | 49.7 ± 17.1 | 52.3 ± 17.0 | 0.22 | |
LDL, mg/dL | 94.0 ± 29.2 | 116.9 ± 40.5 | <0.0001 | |
TG, mg/dL | 152.6 ± 102.2 | 140.9 ± 97.1 | 0.33 | |
N (%) | ||||
Sex – Women | 43 (45) | 184 (54) | 0.13 | |
Race – Caucasian | 83 (87) | 287 (85) | 0.12 | |
Hypertension | 73 (77) | 225 (67) | 0.06 | |
Diabetes mellitus | 27 (28) | 59 (17) | 0.02 | |
Coronary artery disease | 45 (47) | 58 (17) | <0.001 | |
Atrial fibrillation | 18 (19) | 62 (18.4) | 0.94 | |
Smoking | 19 (19) | 87 (25.9) | 0.54 | |
Hyperlipidemia | 76 (80) | 84 (25) | <0.001 | |
Previous stroke | 26 (27) | 81 (24) | 0.50 | |
Previous TIA | 16 (17) | 37 (11) | 0.16 | |
Prior history of cancer | 19 (20) | 49 (15) | 0.20 | |
History of infection | 12 (13) | 17 (5) | 0.009 | |
Antiplatelet/anticoagulant | 63 (66) | 145 (43) | <0.001 | |
Admission NIHSS | 0.4 | |||
<6 | 57 (62.0) | 181 (57.8) | ||
6–15 | 20 (21.7) | 74 (23.6) | ||
>15 | 15 (16.3) | 58 (18.5) | ||
Admission Rankin scale < 2 | 57 (77.0) | 158 (76.3) | 0.9 | |